Compare AXTA & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXTA | HIMS |
|---|---|---|
| Founded | 1910 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paints/Coatings | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 3.6B |
| IPO Year | 2014 | 2019 |
| Metric | AXTA | HIMS |
|---|---|---|
| Price | $26.73 | $19.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 14 |
| Target Price | ★ $35.85 | $28.83 |
| AVG Volume (30 Days) | 2.8M | ★ 32.8M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.74 | 0.51 |
| Revenue | ★ $5,117,000,000.00 | $2,347,637,000.00 |
| Revenue This Year | $3.56 | $19.99 |
| Revenue Next Year | $2.94 | $19.38 |
| P/E Ratio | ★ $15.68 | $40.75 |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $24.94 | $13.74 |
| 52 Week High | $35.72 | $70.43 |
| Indicator | AXTA | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 33.50 | 42.01 |
| Support Level | $26.28 | $13.74 |
| Resistance Level | $31.01 | $27.54 |
| Average True Range (ATR) | 0.77 | 1.69 |
| MACD | 0.04 | -0.17 |
| Stochastic Oscillator | 36.57 | 0.45 |
Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.